Le Lézard
Classified in: Health, Business
Subject: LEG

Dignitana-backed insurance legislation clears Texas House, progresses to Senate

STOCKHOLM, Sweden, April 16, 2021 /PRNewswire/ -- Dignitana AB, world leader in scalp cooling innovation, announces today that HB1588, a Bill mandating insurance plan coverage for scalp cooling in Texas, was passed in the Texas House of Representatives on Friday. The Bill was introduced by Rep. Jeff Leach and 4 other legislators and now moves to the Texas Senate where it will be introduced by Sen. Angela Paxton as SB 862. Once passed in the Senate, the Bill then requires approval by Texas Governor Greg Abbott before being signed into law. If approved, it would take effect in September 2021.

Dignitana began working with Rep. Jeff Leach early in 2019 to initiate this legislation. In May 2019 a similar Bill was passed in the Texas House, but that legislative session ended before the Bill was brought to a vote. The Texas legislature only meets every other year.

"We were honored to work with Rep. Jeff Leach to get this legislation introduced and passed to provide cancer patients with coverage for scalp cooling," said William Cronin, CEO of Dignitana AB. "Removing financial barriers to scalp cooling is critical to our ability to help more patients, and we are happy to see the first steps being made in that direction right here in our home state of Texas."


For More Information Contact 

Melissa Bourestom, VP Corporate Communications,  melissa.bourestom@dignitana.com  +1 469-518-5031


This information was brought to you by Cision http://news.cision.com

The following files are available for download:




SOURCE Dignitana AB

These press releases may also interest you

at 05:05
The Respiratory Monitoring Devices Market report has been added to Technavio's offering. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50...

at 04:40
The suture anchor market is poised to grow by USD 175.49 million during 2021-2025, progressing at a CAGR of almost 6% during the forecast period.  Here is an Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and...

19 jun 2021
Summary Products: Linessa 21 birth control pills (DIN02272903), lot 200049, expiry 03/2023. Issue: Aspen Pharmacare Canada Inc. is recalling one lot due to missing and mispackaged pills. What to do: If you have a package with missing or mispackaged...

19 jun 2021
Core One Labs Inc. , , (the "Company") is pleased to announce that its wholly owned subsidiary Akome Biotech Ltd. ("Akome") has commenced the development of a next-generation psychedelic drug formulation for the purpose of mitigating neurological...

19 jun 2021
UReg FDA Registrations services are easy to use. Simplified process for the user to get back to what matters most - taking care of business. The website visitor simply enters the necessary information to in order get started with FDA registration....

19 jun 2021
As COVID-19 activity continues in Canada, we are tracking a range of epidemiological...

News published on 16 april 2021 at 16:23 and distributed by: